Mason Street Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Mason Street Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-570,080	Closed	-$32.8M	–	1712
2014 Q4	$32.8M	Hold	570,080	–	–	0.23%	91
2014 Q3	$30.6M	Hold	570,080	–	–	0.24%	80
2014 Q2	$29.9M	Hold	570,080	–	–	0.23%	88
2014 Q1	$30.1M	Buy	+570,080	New	+$26.3M	0.24%	82

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Mason Street Advisors's TEVA Position: Q1 2015 in Review

Mason Street Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2015, closing a stake of 570,080 shares — an estimated $32.8M sold.

Mason Street Advisors first reported a position in TEVA in Q1 2014 and held it in 4 quarters. The position peaked at $32.8M in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

Mason Street Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2015 after selling out during the quarter.
Mason Street Advisors sold 570,080 Teva Pharmaceutical Industries Limited shares in Q1 2015, an estimated $32.8M.
Mason Street Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and held it in 4 quarters.
Mason Street Advisors's Teva Pharmaceutical Industries Limited position peaked at $32.8M in Q4 2014.
822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.